Cargando…

Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)

INTRODUCTION: The European Cubicin(®) Outcomes Registry and Experience (EU-CORE(SM)) was a retrospective, non-interventional, multicenter study which evaluated the safety and effectiveness of daptomycin therapy in patients with Gram-positive infections including infective endocarditis (IE). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guleri, Achyut, Utili, Riccardo, Dohmen, Pascal, Petrosillo, Nicola, Piper, Cornelia, Pathan, Rashidkhan, Hamed, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575291/ https://www.ncbi.nlm.nih.gov/pubmed/26168988 http://dx.doi.org/10.1007/s40121-015-0075-9

Ejemplares similares

Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience
por: Seaton, R. Andrew, et al.
Publicado: (2015)

Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE)
por: Cogo, Alberto, et al.
Publicado: (2015)

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
por: Syriopoulou, Vassiliki, et al.
Publicado: (2016)

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2015)

Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE
por: Seaton, R. Andrew, et al.
Publicado: (2016)

A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections
por: Shoemaker, D Matthew, et al.
Publicado: (2006)

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database
por: Seaton, R. Andrew, et al.
Publicado: (2013)

Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry
por: Keil, Felix, et al.
Publicado: (2015)

Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE)
por: Lübbert, Christoph, et al.
Publicado: (2015)

Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections
por: Timerman, Artur, et al.
Publicado: (2013)

Use of dalbavancin in infective endocarditis: a case series
por: Guleri, Achyut, et al.
Publicado: (2021)

A case of endocarditis with cerebral embolism successfully treated with daptomycin
por: Doria, Roberta, et al.
Publicado: (2011)

Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
por: Malizos, K., et al.
Publicado: (2015)

Abiotrophia spp. and Staphylococcus epidermidis Endocarditis Treated with Daptomycin
por: Bishburg, E., et al.
Publicado: (2008)

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report
por: Chen, Liang-Yu, et al.
Publicado: (2011)

596. Distinct, Segregated Daptomycin-Susceptible and Daptomycin-Nonsusceptible Staphylococcus aureus Populations Associated with Tricuspid-Valve Infective Endocarditis
por: Miller, Christopher R, et al.
Publicado: (2019)

Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
por: Peghin, Maddalena, et al.
Publicado: (2019)

Daptomycin for Treatment of S. Epidermidis Endocarditis in an Extremely Preterm Neonate—Outcome and Perspectives
por: Minotti, Chiara, et al.
Publicado: (2022)

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial
por: Pujol, Miquel, et al.
Publicado: (2020)

Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin
por: Bamberger, David M
Publicado: (2007)

Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report
por: Duah, Marylene
Publicado: (2010)

Differences in Method-Specific Vancomycin MICs and Induced Daptomycin Resistance in an Infective Endocarditis Patient
por: Lash, David Benjamin, et al.
Publicado: (2015)

A rationale for combination ampicillin and daptomycin in renal transplant patients with enterococcal infective endocarditis
por: Castro-Lainez, Miriams Teresita, et al.
Publicado: (2018)

Clinical significance of hyperhomocysteinemia in infective endocarditis: A case–control study
por: Iossa, Domenico, et al.
Publicado: (2016)

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2016)

Effectiveness of daptomycin against infective endocarditis caused by highly penicillin-resistant viridans group streptococci
por: Matsuo, Takahiro, et al.
Publicado: (2021)

Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS)
por: Corcione, Silvia, et al.
Publicado: (2022)

Expert consensus recommendations for the provision of infective endocarditis services: updated guidance from the Joint British Societies
por: Sandoe, Jonathan A T, et al.
Publicado: (2023)

Do We Currently Have Guidelines to Select an Adequate Prosthetic Valve to Surgically Treat Active Infective Endocarditis?
por: Dohmen, Pascal M.
Publicado: (2014)

Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry
por: Martone, W J, et al.
Publicado: (2008)

Improved Neurological Outcome in a Patient With Complicated Mitral Valve Endocarditis Treated With Daptomycin-Rifampin Regimen
por: Fatmi, Syed S, et al.
Publicado: (2022)

Nuclear Medicine in Diagnosis of Prosthetic Valve Endocarditis: An Update
por: Musso, Maria, et al.
Publicado: (2015)

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy
por: Xu, Xiaoying, et al.
Publicado: (2016)

Daptomycin-Vancomycin–Resistant Enterococcus faecium Native Valve Endocarditis: Successfully Treated With Off-Label Quinupristin-Dalfopristin
por: Hussain, Khandakar, et al.
Publicado: (2016)

Calculated initial parenteral treatment of bacterial infections: Bacterial endocarditis
por: Dohmen, Pascal M., et al.
Publicado: (2020)

A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model
por: Wang, Jann-Tay, et al.
Publicado: (2022)

Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis
por: Öner, Alper, et al.
Publicado: (2022)

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
por: Storm, Jeremy C, et al.
Publicado: (2012)

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin
por: Jiang, Jhih-Hang, et al.
Publicado: (2015)

Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains
por: Scull, Erin M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vrtqsmk16du0hsmvbnhl4mgc5p